This study presents the design, synthesis, and in vitro evaluation of novel pyridopyrimidine derivatives as potential anticancer agents against gastric cancer. Several compounds showed strong cytotoxic and selective antiproliferative effects in AGS cells. To uncover the mode of action of representative compound, label-free quantitative proteomics was performed, revealing key alterations in proteins linked to various spotted pathways as indicated in IPA analysis.